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Abstract
Objectives: This study was designed to describe Doppler-echocardiography values of Carpentier-Edwards
Perimount Standard (CEPS) and Carpentier-Edwards Perimount Magna (CEPM) aortic prosthetic valves, evaluated by
a single, experienced echo-laboratory, early in the postoperative phase.
Methods: Three-hundred-seventy-seven consecutive patients, who had had a CEPS or a CEPM implanted in our
Hospital due to aortic stenosis and/or insufficiency, underwent baseline Doppler echocardiography evaluation
within 7 days after surgery. Hemodynamic performances of CEPS and CEPM were accurately described, evaluating
flow-dependent (transprosthetic velocities and gradients) and flow-independent (effective orifice area, indexed
effective orifice area and Doppler velocity index) Doppler-echocardiography parameters.
Results: Out of the 377 patients 48.8% were men (n = 184), mean age was 74.63 ± 6.77 years, mean BSA was 1.78
± 0.18 m2, mean ejection fraction was 57.78 ± 8%. Two-hundred and sixty two CEPS and 115 CEPM were
implanted. Comparing size-by-size CEPS with CEPM, both prostheses showed a good hemodynamic profile, with
fairly similar values of pressure gradients (PGmax and mean, in mmHg, = 37,18 ± 11.57 and 20.81 ± 7.44 in CEPS n°
19 compared to 32,47 ± 7,76 and 17,67 ± 4.63 in CEPM n°19 and progressively lower in higher sized prostheses,
having PGmax and mean 15 ± 3,16 and 9.15 ± 1,29 in CEPS n°29 compared to 15,67 ± 1,53 and 9 ± 1 in CEPM n°
29) and EOAi (being 0,65 ± 0,33 cm²/m² in CEPS n°19 compared to 0,77 ± 0,29 cm²/m² in CEPM n°19 and
progressively higher in higher sized prostheses, being 1,28 ± 0,59 cm²/m² in CEPS n°29 compared to 1,07 ± 0,18
cm²/m² in CEPM n°29), the latter resulting, however, basically less flow obstructive.
Conclusions: Our data confirm the good hemodynamic performance of both aortic bioprostheses and the more
favourable hemodynamic profile of CEPM compared to CEPS, pointing out the need to perform routinely an
accurate baseline Doppler-echocardiography evaluation early after surgery to allow an adequate interpretation of
data at follow-up.
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Doppler-echocardiography is widely used to study the
hemodynamic performance of prosthetic aortic valves.
As for native valves, several Doppler echocardiography
parameters (i.e. pressure gradients, effective orifice area,
Doppler velocity index) can be estimated for prosthetic
valves, but the interpretation of the data is much more
difficult. Thus, the assessment of normal and abnormal
function of heart valve prostheses remains challenging
[1-6].
One of the main problems is that prosthetic valves
are, to some degree, obstructive to blood flow. This
makes it difficult to decide whether a calculated Dop-
pler-echocardiography measure represents the perfor-
mance of a normal functioning valve or whether it
indicates prosthetic valve dysfunction [4-10]. The valve
type and size play an important role in determining
hemodynamic features and therefore an adequate inter-
pretation of Doppler-echocardiography data requires the
knowledge of the exact type and size of the implanted
valve. Certainly, the development of tables based on
solid data summarizing normal value range would be
useful to evaluate the Doppler-echocardiography mea-
surements in each patient [4-6].
The hemodynamic performance of aortic prostheses is
attracting new interest due to the influence of patient-
prosthesis-mismatch (PPM) on left ventricular mass
regression and on clinical outcome after valve replace-
ment (AVR) [11,12].
Several studies have tried to give an overview of avail-
able data, but they have been limited by insufficient
patient numbers, different timings of the Doppler-echo-
cardiography evaluation, the large number of valve types
available on the market, and multicenter echocardio-
graphic assessment [4,5].
The aim of our study was to define, early in the post-
operative phase, the Doppler-echocardiography hemody-
namic performance of the bioprosthetic Carpentier-
Edwards Perimount standard (CEPS) aortic valves com-
pared to Carpentier-Edwards Perimount Magna
(CEPM). The study was performed in a single, experi-
enced echo-laboratory. The incidence of PPM, defined
as an effective orifice area indexed (EOAi) <0,85 cm²/m²
[11], was also evaluated. A clinical and Echo follow-up
has been programmed in all patients with the aim to
collect further data useful for the interpretation and
clinical implications of echocardiography results.
Methods
Between January 2007 and October 2010, 377 consecu-
tive patients affected by aortic stenosis (AS) and/or aor-
tic insufficiency (AI), who had had a CEPS (n = 262) or
a CEPM (n = 115) implanted in our Hospital were rec-
luted for this study. This study was approved by our
local ethics committee and informed consent was
obtained from all patients.
Indications for aortic valve replacement were: hemo-
dynamically severe AS, severe AI or moderate AS asso-
ciated with coronary artery disease requiring surgical
revascularization. Patients undergoing an isolated AVR
or those requiring AVR associated with aorto-coronary
bypass grafting (CABG) were included in the study.
Patients with concomitant mitral valve replacement
were excluded from the study.
All patients underwent complete preoperative Dop-
pler-echocardiography evaluation and a control Dop-
pler-echocardiography examination within 7 days after
surgery, following American Society of Echocardiogra-
phy guidelines [13]. The Doppler-echocardiography
examinations were performed with a iE33 (Philips, Eind-
hoven, The Netherlands) in the same echo-laboratory by
four senior echocardiographers. The investigator was
blinded to the prosthetic valve type and size.
Great attention was paid to the assessing of left ventri-
cle outflow tract (LVOT), the most observer-dependent
variable in EOA assessment [14]. The LVOT diameter
was measured and used in single patient for calculating
EOA and EOAi before and after surgery.
All patients were investigated with the use of color-
Doppler, as well as PW and CW Doppler.. The velocity
profiles were traced along the outer border of the spec-
t r a ld i s p l a y .T h ev e l o c i t yt i m ei n t e g r a l( V T I )o fP W
Doppler recordings (sample size 5 mm) from the LVOT
(VTI LVOT) and the VTI of CW Doppler recordings of
the highest transprosthetic velocity (VTI Ao) were eval-
uated and Doppler velocity index (DVI = VTI LVOT/
VTI Ao) was calculated.
The maximum flow velocity (Vmax), maximum
(PGmax) and mean (PGmean) transprosthetic gradients,
EOA, indexed EOA (EOAi), and PPM were calculated.
The mean of three Doppler measurements in patients
with sinus rhythm and the mean of 5 measurements in
patients with atrial fibrillation were calculated. The pre-
sence of physiological intraprosthetic regurgitation and/
or paraprosthetic leak was investigated.
Left ventricle ejection fraction (EF) was estimated
through Simpson’s method.
A clinical and baseline Echo follow-up has been pro-
grammed in all patients; stress echocardiography was
scheduled in patients with persistent features of PPM, to
evaluate the functional hemodynamic performance of
prosthetic aortic valve.
Valve design and surgical procedure
The CEPS aortic valve bioprosthesis (Edwards Life-
sciences, Irvine, California, USA) is a low-profile trileaf-
let valve composed of bovine pericardium preserved in a
buffered glutaraldehyde solution and mounted on a
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t i o nr a n g ef r o m1 9m mt o2 9m m ;a l lo ft h e s es i z e s
were used in this study,
The CEPM aortic xenograft is a modification of the
CEPS valve. Firstly, the width of the sewing ring has
been significantly reduced so that the external diameter
is 2 mm smaller than the corresponding CEPS valve.
Secondly, the sewing cuff has been displaced upstream,
so both sewing cuffs and leaflets remain in a complete
supra-annular position, thus achieving a maximal clear-
ance of the aortic valve orifice. Thirdly, the sewing cuff
is more flexible and scalloped, thereby facilitating the
valve seating and decreasing risk of dehiscence [15].
All patients underwent aortic valve replacement through
conventional midline sternotomy, during total normother-
mic cardiopulmonary bypass. Myocardial protection was
achieved by intermittent anterograde warm blood cardio-
plegia. The aorta was opened, the native aortic valve was
excised and complete removal of calcium from the annulus
was performed. Prosthesis size was selected according to
the size of the aortic annulus, which was incasured using
specific manufacturer’s sizers. Double armed 2-0 Ethibond
sutures were passed through aortic annulus and valve ring.
Once all the sutures were placed, the prosthesis was slid
down to the supraannular position and the sutures were
tied. The aortotomy was closed using 3-0 polypropylene
suture stitches with an over-and-over technique.
Statistical analysis
The continuous variables were expressed as mean values
± standard deviations (SD) and compared using a t-test
and the Mann-Whitney U-test as indicated. Categorical
variables are presented as frequencies and percentages
and compared by Pearson’s c2 test with continuity cor-
rection or 2-sided Fisher exact test as appropriate. Sta-
tistical significance was defined as p-value < 0,05. SPSS
application software version 11.5 (SPSS Inc. Chicago, Ill)
was used to perform the statistical analysis.
Results
Study population
Three hundred seventy seven patients with AS and/or
AI were studied. Out of these patients 48,80% were men
(n = 184). Mean age was 74,63 ± 6,77 years. Mean BSA
was 1,78 ± 0,18 m2. Mean EF was 57,78 ± 8,00% in
whole study population.
CEPS was implanted in 262 patients (69,49%) and
CEPM in 115 patients (30,51%), respectively. The indica-
tion for aortic valve replacement was severe AS in 322
patients (85.41%). Forty-eight patients (14,9%) with AS
underwent CABG and valve replacement, 29 of whom
had a CEPS implanted. There were no statistically signifi-
cant differences in the preoperative clinical characteris-
tics between CEPS and CEPM populations (Table 1).
Carpentier-Edwards Perimount standard (CEPS)
Out of 262 CEPS, 126 were implanted in men (48,09%).
Mean age of patients was 74,71 ± 7,16 years, mean EF
was 57,66 ± 9,03%, mean BSA was 1.78 ± 0.18 m2.
Hemodynamic parameters for each size of CEPS popula-
tion are described in Table 2. The presence of physiolo-
gical intra-prosthetic regurgitation was found in 10%
patients; no patient showed signs of para-prosthetic leak.
Carpentier-Edwards Perimount Magna (CEPM)
Out of 115 CEPM, 58 were implanted in men (50,43%).
Mean age of patients was 74,46 ± 5,95 years, mean EF
was 58,05 ± 8,94%, mean BSA was 1.79 ± 0.18 m2.
Hemodynamic parameters for each size of CEPM popu-
lation are described in Table 3. The presence of physio-
logical intra-prosthetic regurgitation was found in 9%
patients; no patient showed signs of para-prosthetic leak.
Comparison between CEPS and CEPM
The hemodynamic data of CEPS and CEPM patients,
excluding those patients with PPM, showed similar
values of GP max and mean, EOA and EOAi,
Table 1 Population characteristics
CEPS (n = 262) CEPM (n = 115) p value
Mean Age (years) 74,71 ± 7,16 74,46 ± 5,95 0,89
Gender (Male) 126 58 0,236
Mean BSA (m²) 1,78 ± 0,18 1,79 ± 0,18 0,718
Mean EF (%) 57,66 ± 9,03 58,05 ± 8,94 0,355
LVEF < = 40% 9 1 0,177
Hypertension 123 58 0,217
Diabetes 23 12 0,476
Dislipidemia 45 21 0,588
Smoke 34 15 0,799
Atrial Fibrillation 23 12 0,476
Familiarity 24 10 0,964
Obesity 47 20 0,877
Therapy
b-blockers 93 34 0,48
Calcium antagonists 63 27 0,824
ACE inhibitors 110 51 0,333
Nitrates 5 1 0,5
Diuretics 147 62 0,775
Statins 25 9 0,725
Others 140 59 0,821
Aortic valve lesion
Stenosis 89,70% 75,70%
Insufficency 3,80% 8,70%
Mixed 6,10% 6,08%
AVR and CABG 0,40% 9,52%
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tional files 1 &2). The size-by-size hemodynamic para-
meters of the two groups are shown in Table 4.
Incidence of PPM
In CEPS group the cumulative incidence of PPM was
65,26% and resulted higher than in the CEPM group
(42,60%), significantly (p value <0,0001). The incidence
of PPM was inversely correlated to prosthesis size in
both groups (Table 5). However, in CEPM we noticed a
trend towards lower gradients and higher area (Table 6
and 7).
Discussion
The aim of this study was to describe baseline hemody-
namic parameters for CEPS and CEPM prosthetic valves
early in the postoperative phase. Although it has been
shown that an early investigation could differ from a
late investigation, it has also been assessed that when
prosthetic valve dysfunction is suspected a previous
Doppler echocardiography evaluation for comparison
can be helpful [6,16]. Thus, an early Doppler-echocar-
diography assessment of prosthetic valves is of great
importance, providing reference hemodynamic para-
meters useful for an appropriate follow-up. We selected
the two biological prosthesis types more frequently used
in our Hospital and we systematically evaluated all con-
secutive patients in which one of them was implanted.
Previous Doppler-echocardiography studies have sug-
gested that velocity measurements are not suitable for
detecting less than severe obstruction in prosthetic
valves [14,17,18]. Hence, to perform a comprehensive
Doppler-echocardiography assessment of the prostheses,
we evaluated not only flow-dependent parameters (flow
velocities and pressure gradients), but also flow-indepen-
dent parameters (EOA, EOAI and DVI).
In our study, considering all prostheses, the PG max
and mean resulted higher and the EOAi resulted lower
than those reported in Literature, in which a lower
number of patients were evaluated [15,19,20]. These dif-
ferent results could be explained by the early evaluation
of patients, in which a stable hemodynamic condition is
not completely recovered, because of anemia etc. Prob-
ably, an echocardiographic study, performed at the same
time as the reported studies (>15 days), would provide
similar results. However, early echocardiographic para-
meters of only the CEPS and CEPM considered nor-
mally functioning and well-matched are similar to those
reported in Literature and obtained in the later evalua-
tion during the follow-up. In our study, the DVI, a flow
independent parameter, not routinely considered in pre-
vious studies, was evaluated, showing all prostheses nor-
mally functioning, despite quite abnormal gradients and
area values, even in a group with features of PPM.
The consistent number of valves studied and the
homogeneity in valve type, in implantation technique,
and in Doppler-echocardiography evaluation, consider-
ing a flow independent parameter, are the relevant char-
acteristics of this study, giving strength to the
hemodynamic reference values described.
Previous evidence, already discussed in Literature,
s h o w e daw i d er a n g eo fn o r m a l i t yi np r o s t h e t i cv a l v e
hemodynamic parameters [4,5]. Our data confirm this
wide range of variability, pointing out the need to per-
form routinely an accurate evaluation of aortic prosthe-
tic valve hemodynamic profile in the early post-
Table 2 EarlyDoppler-Echocardiography evaluation of CEPS
Size n BSA (m²) LVOT (mm) PG max (mmHg) PG mean (mmHg) DVI EOA (cm²) EOAi (cm²/m²)
19 101 1,63 ± 0,4 18,42 ± 2,15 37,18 ± 11,57 20,81 ± 7,44 0,42 ± 0,10 1,15 ± 0,50 0,65 ± 0,33
21 76 1,76 ± 0,19 18,54 ± 3,75 31,00 ± 8,90 16,85 ± 5,31 0,48 ± 0,15 1,37 ± 0,41 0,79 ± 0,23
23 58 1,84 ± 0,16 20,91 ± 3,71 27,24 ± 12,07 14,05 ± 6,04 0,45 ± 0,09 1,60 ± 0,41 0,89 ± 0,27
25 19 1,89 ± 0,15 21,45 ± 2,04 24,50 ± 7,67 12,87 ± 4,09 0,43 ± 0,12 1,52 ± 0,39 0,81 ± 0,23
27 4 1,91 ± 0,19 25,50 ± 1,29 21,50 ± 6,76 10,67 ± 6,30 0,40 ± 0,08 1,98 ± 0,28 1,1 ± 0,26
29 4 2,10 ± 0,23 27,50 ± 1,29 15,00 ± 3,16 9,15 ± 1,29 0,44 ± 0,05 2,55 ± 1,26 1,28 ± 0,59
Table 3 Early Doppler-Echocardiography evaluation of CEPM
Size n BSA (m²) LVOT (mm) PG max (mmHg) PG mean (mmHg) DVI EOA (cm²) EOAi (cm²/m²)
19 30 1,59 ± 0,15 18,07 ± 1,86 32,47 ± 7,76 17,67 ± 4,63 0,46 ± 0,14 1,22 ± 0,49 0,77 ± 0,29
21 43 1,77 ± 0,16 19,41 ± 2,24 28,93 ± 9,16 15,79 ± 5,01 0,60 ± 0,46 1,42 ± 0,59 0,80 ± 0,32
23 24 1,90 ± 0,18 20,49 ± 2,61 23,90 ± 7,06 13,04 ± 4,40 0,48 ± 0,12 1,64 ± 0,42 0,79 ± 0,36
25 13 1,89 ± 0,13 22,17 ± 2,71 26,36 ± 6,90 14,18 ± 3,40 0,49 ± 0,14 2,11 ± 0,58 1,12 ± 0,36
27 2 1,93 ± 0,04 22,50 ± 3,53 14,00 ± 1,41 5 ± 4,24 0,71 2,45 ± 0,21 1,27 ± 0,14
29 3 1,86 ± 0,12 26,33 ± 2,89 15,67 ± 1,53 9 ± 1 0,37 ± 0,01 1,99 ± 0,36 1,07 ± 0,18
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Doppler-echocardiography parameters from the early
baseline investigation may be a useful warning sign dur-
ing follow-up.
To our knowledge no previous studies have compared
a large sample of CEPS and CEPM prosthetic valves
divided size-by-size, evaluated in the same protocol by a
single echo-laboratory, in the early post-operative phase.
Our study did not show any statistically significant dif-
ferences between in both prostheses PGmax, DVI and
EOAi, except for EOAi in 25-size prosthesis and DVI in
21- and 23-size prosthesis. Nevertheless, CEPM had
basically lower PG max and mean, and higher EOAi
compared to CEPS size-by-size.
Generally, prosthetic valves are inherently stenotic
due to the sewing ring as well as the stent itself that
may contribute to reducing the existing orifice area
and therefore lead to PPM. The influence of PPM on
LV mass regression and on clinical outcome after AVR
is attracting new interest [11,12]. PPM, as we know,
has prognostic implications particularly in the presence
of preoperative left ventricular dysfunction, in the lack
of left ventricular mass regression and contributes to
increased mortality and the number of cardiac events
after AVR [21,22]. PPM is a frequent cause of
increased trans-prosthetic gradient. It is important to
differentiate this condition from acquired prosthetic
stenosis which may result from leaflet calcification,
pannus overgrowth or thrombus formation. In our
s t u d yt h ei n c i d e n c eo fP P Mw a sh i g h e rt h a nr e p o r t e d
in Literature in both prostheses and could reflect the
impaired hemodynamics of early post-operative phase
[23,24] Several studies have tried to give an overview
of available data, but they have been limited by insuffi-
cient patient numbers, different timings of the Dop-
pler-echocardiography evaluation, the large number of
valve types available on the market, and multicenter
echocardiographic assessment [4,5]. Our study was
performed in a single, experienced echo-laboratory.
The incidence of PPM, defined as EOAi <0,85 cm²/m²
was evaluated according Literature criteria [11]. A
DVI, derived from the ratio between VTI LVOT and
the VTI Ao, was measured as further index of well
functioning aortic prosthetic valve, similar to a native
valve, assuming as normal value a DVI >0.40. As
reported in the methods section, a late clinical and
echocardiographic evaluation of all the patients has
been programmed with the aim of detecting the true
PPM from the transient, apparent, early one.
The following conditions were identified in the early
evaluation: patients with EOAi >0.85 cm²/m² and
DVI>0.40 (n° 130: CEPS n°85, CEPM n°45), patients
with EOAi <0.85 cm²/m² and DVI>0.40 (n° 141: CEPS n
°101, CEPM n° 40) and patients with EOAi <0.85 cm²/
m² and DVI<0.40 (n° 112: CEPS n°82, CEPM n°30). In
the latter condition stress echocardiography has been
scheduled to evaluate the functional hemodynamic
performance.
Conclusions
A complete early Doppler-echocardiography evaluation
of aortic prosthetic valves, including flow-dependent and
independent Doppler echocardiography parameters, pro-
vides a baseline description of the prosthesis. Each
patient who underwent aortic valve replacement should
be supplied with Doppler echocardiography ID of the
Table 4 Comparison between CEPS and CEPM
CEPS n° 91 CEPM n°66 P value
19 19 11
PG max (mmHg) 37,18 ± 11,57 32,47 ± 7,76 0,12
DVI 0,42 ± 0,10 0,46 ± 0,14 0,11
EOAi (cm²/m²) 0,65 ± 0,33 0,77 ± 0,29 0,12
21 27 24
PG max (mmHg) 31,00 ± 8,90 28,93 ± 9,16 0,34
DVI 0,48 ± 0,15 0,60 ± 0,46 0,038
EOAi (cm²/m²) 0,79 ± 0,23 0,80 ± 0,32 0,7
23 26 15
PG max (mmHg) 27,24 ± 12,07 23,90 ± 7,06 0,22
DVI 0,45 ± 0,09 0,48 ± 0,12 0,05
EOAi (cm²/m²) 0,89 ± 0,27 0,79 ± 0,36 0,43
25 11 11
PG max (mmHg) 24,50 ± 7,67 26,36 ± 6,90 0,85
DVI 0,43 ± 0,12 0,49 ± 0,14 0,16
EOAi (cm²/m²) 0,81 ± 0,23 1,12 ± 0,36 0,027
27 42
PG max (mmHg) 21,50 ± 6,76 14 ± 1,41 0,22
DVI 0,40 ± 0,08 0,71 0,84
EOAi (cm²/m²) 1,1 ± 0,26 1,27 ± 0,14 0,47
29 43
PG max (mmHg) 15,00 ± 3,16 15,67 ± 1,53 0,75
DVI 0,44 ± 0,05 0,37 ± 0,01 0,18
EOAi (cm²/m²) 1,28 ± 0,59 1,07 ± 0,18 0,59
Table 5 Prothesis Mismatch
Size CEPS CEPM P Value
19 82 (81,18%) 19 (63,33%) 0,0001
21 49 (64,47%) 19 (44,18%) 0,0001
23 32 (55,17%) 9 (37,5%) 0,0001
25 8 (42,10%) 2 (15,38%) 0,0001
27 00
29 00
Cumulative 171 (65,26%) 49 (42,60%)
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CEPS (N°262) P value CEPM (N°115) P value
19 PPM (82) No PPM (19) PPM (19) No PPM (11)
PG max (mmHg) 36,97 ± 12,29 38,05 ± 7,99 0,72 34,65 ± 7,45 29,36 ± 7,31 0,077
PG mean (mmHg) 20,65 ± 7,86 21,47 ± 5,36 0,67 18,69 ± 4,54 14,60 ± 2,84 0,018
DVI 0,39 ± 0,08 0,53 ± 0,12 0,0001 0,49 ± 0,13 0,59 ± 0,08 0,017
EOAi (cm²/m²) 0,58 ± 0,12 1,13 ± 0,44 0,0001 0,71 ± 0,39 1,03 ± 0,40 0,005
21 PPM (49) No PPM (27) PPM (19) No PPM (24)
PG max (mmHg) 31,79 ± 8,72 29,56 ± 9,20 0,30 31,15 ± 12,78 28,42 ± 10,95 0,46
PG mean (mmHg) 17,43 ± 5,09 15,81 ± 5,64 0,22 17,36 ± 6,24 15,95 ± 5,52 0,43
DVI 0,42 ± 0,09 0,59 ± 0,18 0,0001 0,59 ± 0,47 0,60 ± 0,26 0,92
EOAi (cm²/m²) 0,65 ± 0,11 1,04 ± 0,19 0,0001 0,65 ± 0,18 1,03 ± 0,28 #####
23 PPM (32) No PPM (26) PPM (9) No PPM (15)
PG max (mmHg) 27,86 ± 12,86 26,46 ± 11,22 0,66 22,11 ± 7,04 24,28 ± 7,61 0,49
PG mean (mmHg) 14,97 ± 6,99 12,92 ± 4,50 0,20 12, 00 ± 4,80 13,36 ± 4,53 0,50
DVI 0,40 ± 0,07 0,51 ± 0,9 0,0001 0,63 ± 0,45 0,52 ± 0,12 0,39
EOAi (cm²/m²) 0,71 ± 0,11 1,16 ± 0,20 0,0001 0,85 ± 0,43 1,03 ± 0,21 0,20
25 PPM (8) No PPM (11) PPM (2) No PPM (11)
PG max (mmHg) 28,25 ± 10,82 23,90 ± 6,52 0,30 36,00 ± 9,89 20, 55 ± 8,38 0,23
PG mean (mmHg) 14,63 ± 5,55 12,80 ± 4,10 0,43 18,00 ± 4,24 10,90 ± 4,31 0,064
DVI 0,32 ± 0,15 0,49 ± 0,06 0,005 0,44 ± 0,11 0,57 ± 0,13 0,26
EOAi (cm²/m²) 0,63 ± 0,13 0,85 ± 0,41 0,17 0,68 1,29 ± 0,40 0,22
Table 7 Comparison of Hemodynamics Performance between CEPS and CEPM with and without PPM
CEPS CEPM P value CEPS CEPM P value
19 PPM (82) PPM (19) No PPM (19) No PPM (11)
PG max (mmHg) 36,97 ± 12,29 34,65 ± 7,45 0,45 38,05 ± 7,99 29,36 ± 7,31 0,006
PG mean (mmHg) 20,65 ± 7,86 18,69 ± 4,54 0,34 21,47 ± 5,36 14,60 ± 2,84 0,0001
DVI 0,39 ± 0,08 0,49 ± 0,13 0,007 0,53 ± 0,12 0,59 ± 0,08 0,17
EOAi (cm²/m²) 0,58 ± 0,12 0,71 ± 0,39 0,17 1,13 ± 0,44 1,03 ± 0,40 0,55
21 PPM (49) PPM (19) No PPM (27) No PPM (24)
PG max (mmHg) 31,79 ± 8,72 31,15 ± 12,78 0,81 29,56 ± 9,20 28,42 ± 10,95 0,69
PG mean (mmHg) 17,43 ± 5,09 17,36 ± 6,24 0,96 15,81 ± 5,64 15,95 ± 5,52 0,93
DVI 0,42 ± 0,09 0,59 ± 0,47 0,017 0,59 ± 0,18 0,60 ± 0,26 0,89
EOAi (cm²/m²) 0,65 ± 0,11 0,65 ± 0,18 0,99 1,04 ± 0,19 1,03 ± 0,28 0,85
23 PPM (32) PPM (9) No PPM (26) No PPM (15)
PG max (mmHg) 27,86 ± 12,86 22,11 ± 7,04 0,09 26,46 ± 11,22 24,28 ± 7,61 0,52
PG mean (mmHg) 14,97 ± 6,99 12, 00 ± 4,80 0,24 12,92 ± 4,50 13,36 ± 4,53 0,77
DVI 0,40 ± 0,07 0,63 ± 0,45 0,16 0,51 ± 0,9 0,52 ± 0,12 0,67
EOAi (cm²/m²) 0,71 ± 0,11 0,85 ± 0,43 0,37 1,16 ± 0,20 1,03 ± 0,21 0,095
25 PPM (8) PPM (2) No PPM (11) No PPM (11)
PG max (mmHg) 28,25 ± 10,82 36,00 ± 9,89 0,39 23,90 ± 6,52 20, 55 ± 8,38 0,34
PG mean (mmHg) 14,63 ± 5,55 18,00 ± 4,24 0,45 12,80 ± 4,10 10,90 ± 4,31 0,33
DVI 0,32 ± 0,15 0,44 ± 0,11 0,31 0,49 ± 0,06 0,57 ± 0,13 0,15
EOAi (cm²/m²) 0,63 ± 0,13 0,68 0,73 0,85 ± 0,41 1,29 ± 0,40 0,063
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Page 6 of 7implanted prosthesis to allow an adequate interpretation
of Doppler echocardiography examinations at follow-up.
Additional material
Additional File 1: Movie Clip 1: CEPS aortic prostethic valve n°23 well
functioning;
Additional File 2: Movie Clip 2: CEPM aortic prostethic valve n°23 well
functioning;
List of Abbreviations
AI: Aortic insufficiency; AS: aortic stenosis; AVR: Aortic valve replacement;
BSA: Body Surface Area; CABG: coronary-aortic bypass grafting; CEPM:
Carpentier-Edwards Perimount Magna; CEPS: Carpentier-Edwards Perimount
Standard; CW: Continous-Wave; DVI: Doppler velocity index; EF: ejection
fraction; EOA: effective orifice area; EOAi: indexed effective orifice area; LVOT:
left ventricle outflow tract; PW: Pulse-Wave; PPM: patient-prosthesis-
mismatch; VTI: velocity time integral.
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